Long

Cerevel Therapeutics Announces Positive Topline Results for Dari

51
CERE: Cerevel Therapeutics Holdings, Inc.
2022-02-15 06:30:00
Cerevel Therapeutics Announces Positive Topline Results for Darigabat in Phase 1 Clinical Trial in Acute Anxiety

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.